NRCAM and neuroblastoma: Further validation of the NRCAM alternative isoform protein in neuroblastoma patient samples as well as research on NRCAM-specific ligands and antibodies that trigger internalization will further strengthen the case for alternative NRCAM as a delivery target for neuroblastoma.